• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-19a-3p 的下调通过激活前列腺癌中的 TGF-β 信号通路促进侵袭、迁移和骨转移。

Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.

机构信息

Department of Orthopaedic Surgery, The Affiliated Hospital of Zunyi Medical College, Zunyi, Guizhou 563003, P.R. China.

Department of Pelvic Floor Center, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510655, P.R. China.

出版信息

Oncol Rep. 2018 Jan;39(1):81-90. doi: 10.3892/or.2017.6096. Epub 2017 Nov 13.

DOI:10.3892/or.2017.6096
PMID:29138858
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5783607/
Abstract

Constitutive activation of TGF‑β signaling pathway is a well-documented mechanism responsible for the bone metastasis of prostate cancer (PCa). MicroRNAs (miRNAs) have been reported to be crucial for the activation of TGF‑β signaling via targeting downstream components of TGF‑β signaling pathway. Here, we report that miR‑19a‑3p is downregulated in bone metastatic PCa tissues and cells. Upregulation of miR‑19a‑3p suppresses invasion, migration in vitro and inhibits bone metastasis in vivo in PCa cells. Conversely, silencing miR‑19a‑3p yields the opposite effect. Our results further demonstrate that miR‑19a‑3p inhibits invasion and migration abilities of PCa cells via targeting downstream effectors of TGF‑β signaling, SMAD2 and SMAD4, resulting in the inactivation of TGF‑β signaling. Therefore, our results uncover a novel mechanistic understanding of miR‑19a‑3p-induced suppressive role in bone metastasis of PCa, which will facilitate the development of effective cancer therapy methods against PCa.

摘要

TGF-β 信号通路的组成性激活是导致前列腺癌(PCa)骨转移的一个有充分文献记录的机制。已经有报道称,microRNAs(miRNAs)通过靶向 TGF-β 信号通路的下游成分,对于 TGF-β 信号的激活至关重要。在这里,我们报告 miR-19a-3p 在骨转移的 PCa 组织和细胞中下调。miR-19a-3p 的上调抑制了 PCa 细胞的体外侵袭和迁移,并抑制了体内骨转移。相反,沉默 miR-19a-3p 则产生相反的效果。我们的结果进一步表明,miR-19a-3p 通过靶向 TGF-β 信号的下游效应物 SMAD2 和 SMAD4,抑制 PCa 细胞的侵袭和迁移能力,从而使 TGF-β 信号失活。因此,我们的结果揭示了 miR-19a-3p 在抑制 PCa 骨转移中的作用的新机制理解,这将有助于开发针对 PCa 的有效癌症治疗方法。

相似文献

1
Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.miR-19a-3p 的下调通过激活前列腺癌中的 TGF-β 信号通路促进侵袭、迁移和骨转移。
Oncol Rep. 2018 Jan;39(1):81-90. doi: 10.3892/or.2017.6096. Epub 2017 Nov 13.
2
Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.miR-505-3p 下调预示前列腺癌骨无转移生存不良。
Oncol Rep. 2019 Jan;41(1):57-66. doi: 10.3892/or.2018.6826. Epub 2018 Oct 25.
3
The TGF-β signalling negative regulator PICK1 represses prostate cancer metastasis to bone.转化生长因子-β信号负调控因子PICK1抑制前列腺癌向骨转移。
Br J Cancer. 2017 Aug 22;117(5):685-694. doi: 10.1038/bjc.2017.212. Epub 2017 Jul 11.
4
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.miR-141-3p 的下调通过激活 NF-κB 信号通路促进前列腺癌骨转移。
J Exp Clin Cancer Res. 2017 Dec 4;36(1):173. doi: 10.1186/s13046-017-0645-7.
5
Transcriptional downregulation of miR-133b by REST promotes prostate cancer metastasis to bone via activating TGF-β signaling.REST 通过下调 miR-133b 促进前列腺癌骨转移,从而激活 TGF-β 信号通路。
Cell Death Dis. 2018 Jul 13;9(7):779. doi: 10.1038/s41419-018-0807-3.
6
miR‑19a‑3p targets PMEPA1 and induces prostate cancer cell proliferation, migration and invasion.微小RNA-19a-3p靶向前列腺膜蛋白1并诱导前列腺癌细胞增殖、迁移和侵袭。
Mol Med Rep. 2016 May;13(5):4030-8. doi: 10.3892/mmr.2016.5033. Epub 2016 Mar 21.
7
MicroRNA-539 functions as a tumour suppressor in prostate cancer via the TGF-β/Smad4 signalling pathway by down-regulating DLX1.MicroRNA-539 通过下调 DLX1 抑制 TGF-β/Smad4 信号通路在前列腺癌中发挥肿瘤抑制作用。
J Cell Mol Med. 2019 Sep;23(9):5934-5948. doi: 10.1111/jcmm.14402. Epub 2019 Jul 12.
8
SMAD3/SP1 complex-mediated constitutive active loop between lncRNA PCAT7 and TGF-β signaling promotes prostate cancer bone metastasis.SMAD3/SP1 复合物介导的长链非编码 RNA PCAT7 和 TGF-β 信号之间的组成性激活环促进前列腺癌骨转移。
Mol Oncol. 2020 Apr;14(4):808-828. doi: 10.1002/1878-0261.12634. Epub 2020 Feb 8.
9
IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.IFITM3 通过介导 TGF-β 信号通路的激活促进前列腺癌细胞的骨转移。
Cell Death Dis. 2019 Jul 4;10(7):517. doi: 10.1038/s41419-019-1750-7.
10
Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway.转化生长因子-β通过诱导 microRNA-96 并激活 mTOR 通路促进前列腺骨转移。
Oncogene. 2015 Sep 3;34(36):4767-76. doi: 10.1038/onc.2014.414. Epub 2014 Dec 22.

引用本文的文献

1
miRNA-mediated resistance mechanisms in prostate cancer: implications for targeted therapy and metastatic progression.前列腺癌中微小RNA介导的耐药机制:对靶向治疗和转移进展的影响
Med Oncol. 2025 Aug 29;42(10):454. doi: 10.1007/s12032-025-03006-7.
2
Association of miRNA-17-92 Cluster with Muscle Invasion in Bladder Cancer.miRNA-17-92簇与膀胱癌肌肉浸润的相关性
Int J Mol Sci. 2025 Aug 5;26(15):7546. doi: 10.3390/ijms26157546.
3
Bone metastases of prostate cancer: Molecular mechanisms, targeted diagnosis and targeted therapy (Review).

本文引用的文献

1
Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.miR-196b-5p维持癌症干性通过激活STAT3信号通路促进结肠癌细胞的化学抗性。
Oncotarget. 2017 Jul 25;8(30):49807-49823. doi: 10.18632/oncotarget.17971.
2
miR‑150 inhibits proliferation and tumorigenicity via retarding G1/S phase transition in nasopharyngeal carcinoma.微小RNA-150通过延缓鼻咽癌G1/S期转换来抑制细胞增殖和致瘤性。
Int J Oncol. 2017 Apr;50(4):1097-1108. doi: 10.3892/ijo.2017.3909. Epub 2017 Mar 10.
3
Expression of oncogenic miR-17-92 and tumor suppressive miR-143-145 clusters in basal cell carcinoma and cutaneous squamous cell carcinoma.
前列腺癌骨转移:分子机制、靶向诊断与靶向治疗(综述)
Oncol Rep. 2025 Apr;53(4). doi: 10.3892/or.2025.8879. Epub 2025 Feb 21.
4
Distinct mRNA expression profiles and miRNA regulators of the PI3K/AKT/mTOR pathway in breast cancer: insights into tumor progression and therapeutic targets.乳腺癌中PI3K/AKT/mTOR通路独特的mRNA表达谱及miRNA调控因子:对肿瘤进展和治疗靶点的见解
Front Oncol. 2025 Jan 9;14:1515387. doi: 10.3389/fonc.2024.1515387. eCollection 2024.
5
Current landscape of exosomal non-coding RNAs in prostate cancer: Modulators and biomarkers.前列腺癌中外泌体非编码RNA的现状:调节剂与生物标志物
Noncoding RNA Res. 2024 Jul 20;9(4):1351-1362. doi: 10.1016/j.ncrna.2024.07.003. eCollection 2024 Dec.
6
Unveiling the Cutting-Edge Impact of Polarized Macrophage-Derived Extracellular Vesicles and MiRNA Signatures on TGF-β Regulation within Lung Fibroblasts.揭示极化巨噬细胞衍生细胞外囊泡和 miRNA 特征对肺成纤维细胞中 TGF-β 调控的前沿影响。
Int J Mol Sci. 2024 Jul 8;25(13):7490. doi: 10.3390/ijms25137490.
7
Dysregulation of exosomal miRNAs and their related genes in head and neck cancer patients.头颈部癌症患者中细胞外体 miRNAs 及其相关基因的失调。
Future Oncol. 2024;20(21):1479-1493. doi: 10.1080/14796694.2024.2351355. Epub 2024 May 30.
8
The regulatory process and practical significance of non-coding RNA in the dissemination of prostate cancer to the skeletal system.非编码RNA在前列腺癌向骨骼系统转移中的调控过程及实际意义。
Front Oncol. 2024 Mar 21;14:1358422. doi: 10.3389/fonc.2024.1358422. eCollection 2024.
9
Integrative Metabolomic Analysis of Serum and Selected Serum Exosomal microRNA in Metastatic Castration-Resistant Prostate Cancer.转移性去势抵抗性前列腺癌血清及选定血清外泌体微小RNA的综合代谢组学分析
Int J Mol Sci. 2024 Feb 23;25(5):2630. doi: 10.3390/ijms25052630.
10
Emerging role of transforming growth factor-β-regulated long non-coding RNAs in prostate cancer pathogenesis.转化生长因子-β调控的长链非编码RNA在前列腺癌发病机制中的新作用
Cancer Pathog Ther. 2022 Dec 24;1(3):195-204. doi: 10.1016/j.cpt.2022.12.003. eCollection 2023 Jul.
致癌性miR-17-92和抑癌性miR-143-145簇在基底细胞癌和皮肤鳞状细胞癌中的表达。
J Dermatol Sci. 2017 May;86(2):142-148. doi: 10.1016/j.jdermsci.2017.01.012. Epub 2017 Jan 31.
4
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer.胸腺素β10是肿瘤发生和转移的关键调节因子,也是乳腺癌中的一种新型血清标志物。
Breast Cancer Res. 2017 Feb 8;19(1):15. doi: 10.1186/s13058-016-0785-2.
5
A panel of microRNA signature in serum for colorectal cancer diagnosis.用于结直肠癌诊断的血清微小RNA特征组合
Oncotarget. 2017 Mar 7;8(10):17081-17091. doi: 10.18632/oncotarget.15059.
6
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.微小RNA-466通过直接调控成骨转录因子RUNX2抑制前列腺癌的肿瘤生长和骨转移。
Cell Death Dis. 2017 Jan 26;8(1):e2572. doi: 10.1038/cddis.2017.15.
7
MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma.微小RNA-19a通过调节骨髓瘤中的PTEN/AKT/pAKT信号通路发挥癌基因作用。
Leuk Lymphoma. 2017 Apr;58(4):932-940. doi: 10.1080/10428194.2016.1213827. Epub 2016 Nov 10.
8
MicroRNA expression profiling of Chinese follicular lymphoma by microarray: A preliminary study.利用基因芯片对中国滤泡性淋巴瘤进行微小RNA表达谱分析:一项初步研究。
Int Immunopharmacol. 2016 Oct;39:41-47. doi: 10.1016/j.intimp.2016.07.006. Epub 2016 Jul 10.
9
N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells.N-钙黏蛋白通过ErbB信号通路促进前列腺癌细胞的上皮-间质转化和癌症干细胞样特征。
Int J Oncol. 2016 Feb;48(2):595-606. doi: 10.3892/ijo.2015.3270. Epub 2015 Nov 26.
10
Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.雌激素受体阳性和阴性乳腺癌细胞系中miRNA-mRNA-lncRNA网络的分析
J Cell Mol Med. 2015 Dec;19(12):2874-87. doi: 10.1111/jcmm.12681. Epub 2015 Sep 28.